A new study published in the Nature Partner Journals Parkinson's disease showed that REM sleep behavior disorder (RBD) was ...

The Algae4IBD project is exploring the untapped potential of algae and cyanobacteria to manage inflammatory bowel disease ...

Innovator IBD 50 ETF (FFTY) is outperforming major indexes in 2024. See here for an analysis of its risks, and whether this ...

One of the easiest ways to find stock market leaders is to use the Relative Strength At New Highs screen in the IBD Screener. This exclusive IBD screen focuses on ideas with market-beating performance ...

Mutual funds own 56% of outstanding shares. More funds have been net buyers of the stock over the past seven quarters. In the ...

ACROBiosystems, together with Leica Biosystems, Molecular Devices, and Leica Microsystems, hosted the OrganoAs ...

Depression may raise the risk for inflammatory conditions; the risk for Parkinson's disease persists after adjusting for ...

The global gastrointestinal (GI) devices market is on a steady growth trajectory, projected to grow at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This ...

Inflammatory bowel disease is not significantly associated with an increased risk for colonic perforation during diagnostic colonoscopy.

Vitamin D significantly affects IBD by influencing severity, inflammation, and patient outcomes. Optimizing vitamin D levels ...

Whether it’s safe to stop anti-TNF treatment in patients with inflammatory bowel disease (IBD) in remission remains unclear. In the Spanish EXIT study, anti-TNF withdrawal in selected patients with ...

New IBD research shows that, even during clinical remission, people living with Crohn's disease continue to experience greater work impairment than the general population The new campaign aims to ...